Last edition
News about "hepatocellular carcinoma"
Akeso Doses First Patient in Global Trial of Cadonilimab for PD-1 Resistant Liver Cancer
COMPASSION-36, the first global Phase III trial of Cadonilimab, is underway in China, the US, and Europe. It marks a key step in Akeso's effort to advance cancer immunotherapy beyond single-target treatments.
HepatoCellular Carcinoma | 15/09/2025 | By Dineshwori
NAYA Therapeutics Partners with Atley Solutions on Astatine-211 Radio Pharmaceuticals
NAYA Therapeutics will leverage Atley’s clinical manufacturing network and establish additional GMP sites using the Atley C100 for the final clinical-dose manufacturing of 211 At Targeted Alpha Therapies.
Hepatocellular Carcinoma | 04/09/2025 | By Dineshwori
Atezolizumab will be provided by Genentech for use in Pilatus’ clinical research; PLT012 is Pilatus’ immunomodulatory candidate.
Hepatocellular Carcinoma | 18/08/2025 | By Abha
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy